Société Brainstorm Cell Therapeutics Inc.
Actions
BCLI
US10501E2019
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,5345 USD | +0,47 % | +0,47 % | +95,79 % |
Métier
Nombre d'employés: 29
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/12 |
Chief Tech/Sci/R&D Officer | - | 12/05/22 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/07/23 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/07 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
General Counsel | - | 12/05/22 | |
Mary Kay Turner
LAW | General Counsel | - | 07/08/17 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/09/00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 30/03/20 |
Director/Board Member | 63 | 28/10/21 | |
Director/Board Member | 61 | 05/02/18 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Nir Naor
BRD | Director/Board Member | 50 | 20/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 68 341 857 | 59 284 308 ( 86,75 %) | 0 | 86,75 % |
Coordonnées société
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+95,79 % | 36,53 M | |
+1,51 % | 42,75 Md | |
+8,57 % | 41,34 Md | |
+49,22 % | 41,61 Md | |
-12,36 % | 26,59 Md | |
+8,92 % | 25,49 Md | |
-25,13 % | 18,12 Md | |
+29,17 % | 12,24 Md | |
-3,12 % | 11,76 Md | |
+6,35 % | 11 Md |
- Bourse
- Actions
- Action BCLI
- Société Brainstorm Cell Therapeutics Inc.